Objective: Specialist services for dementia are seeing an increasing number of patients. We investigated whether interactional and linguistic features in the communication behavior of patients with memory problems could help distinguish between those with problems secondary to neurological disorders (ND) and those with functional memory disorder (FMD).
D
emographic changes have increased pressure on specialist services for patients with dementia, causing health care professionals and service commissioners in many countries to focus on improvements to diagnostic pathways for people with memory complaints. In the United Kingdom, the national dementia strategy identified the closure of the "dementia gap" (the difference between the predicted number of people with dementia versus those diagnosed as having dementia) as an area of particular concern. 1 An audit by the Royal College of Psychiatrists found that the number of people assessed in specialist clinics with memory concerns increased 4-fold between 2010 and 2013. 2 A further 31% increase was seen from 2013 to 2014. Although the "dementia gap" has narrowed with this increase in activity, it has not been reduced at the same rate at which the number of memory clinic referrals has risen. 3, 4 One reason for this is that the proportion of patients with functional memory disorder (FMD) or other nonprogressive memory disorders has also increased. 3, 5, 6 The referral of patients to memory clinics is costly and can cause avoidable distress. 7, 8 These observations-combined with studies showing that current screening procedures lack sensitivity 9 -suggest that case selection for referral to specialist clinics is suboptimal.
It is well recognized that patients exhibit linguistic impairments and deficits in spontaneous speech even in the earlier stages of dementia. 10, 11 Language impoverishment, through grammatical simplification, loss of vocabulary, semantic paraphasias, and overuse of semantically empty words, becomes progressively evident in dementia, as do impaired semantic processing and classification errors. [12] [13] [14] [15] Although the analysis of patients' language may therefore contribute toward identifying those at risk of developing dementia, the detection of such language impoverishment (i) requires complex linguistic analysis, (ii) may be diagnostically ambiguous, and (iii) does not take account of more directly observable conversational or interactional features of language. Automated analysis of spontaneous speech could address some of the practical problems with the assessment of language in routine practice. 16, 17 However, to date, it remains uncertain how well this method would perform as a screening procedure in clinical situations. Moreover, previous approaches have focused on vocal/aural features of speech, abstracted from their communicative context. Thus, they would not capture impairments in specifically interactional capabilities, that can be detected with methods focusing on the coconstruction of conversation and which may well be particularly early and specific indicators of cognitive complaints secondary to neurological disorders (ND).
We aimed to use problems with communication between patients, doctors, and third parties in medical consultations as a diagnostic tool. Our project was inspired by studies demonstrating the potential of conversation analysis (CA)-derived interactional and linguistic observations in the differentiation of epilepsy and (nonepileptic) dissociative seizures. 18 Using previously described conversational profiles of patients with seizures, CA experts were able to predict the medical "gold standard" diagnosis of epilepsy or dissociative seizures with a sensitivity and specificity of around 85%. 19 Mirroring the study design pursued in seizure clinics, conversation analysts have previously described a number of interactional and linguistic features, which appeared to distinguish patients with ND from those with FMD in 2 qualitative studies. 20, 21 The current paper describes the initial validation and assessment of a quantitative diagnostic scoring aid (DSA) guiding analysts to rate each doctor-patient encounter on a number of the interactional, topical, and linguistic features described in these qualitative studies. Part 1 of the present study was designed to establish an optimal discriminatory DSA cut-off for the distinction of ND and FMD. In part 2 of this study this numeric cut-off was applied prospectively to DSA ratings of clinic interactions with newly recruited patients.
METHODS

Participant Recruitment and Assessment
Participant recruitment and assessment have been described in a previous article exploring the scope of automated analysis of conversational interaction. 22 Briefly, all participants had been referred to the neurology-led memory clinic in Sheffield, United Kingdom. Patients are routinely encouraged to bring someone along to their memory clinic appointment if possible [accompanying person (AP)]. A member of the study team obtained written informed consent before the encounter with a neurologist. Participants and AP were only consented if they had capacity to make their own decision about participation and used English as their first language. Participants whose diagnosis remained uncertain and those whose cognitive problems were considered to be due to other causes than ND or FMD were excluded.
Participants were investigated and followed-up by consultant neurologists specializing in memory disorders according to clinical need. Participants were referred for detailed neuropsychological testing and brain magnetic resonance imaging (MRI). The neuropsychological battery (see Wakefield et al 23 for details) included the mini mental state examination (MMSE), 24 tests of short and long-term memory (verbal and nonverbal), 25 abstract reasoning, 26, 27 attention and executive function, 28 language comprehension, naming by confrontation, category, and letter fluency. 29 All participants were recruited before their first ever appointment in the memory clinic. Most patients with ND were in the early disease stages, but some already had moderately severe dementia. Diagnoses were reached by multidisciplinary consensus; taking into account clinical history, neurological examination, neuropsychological scores, and neuroradiologic findings. Alzheimer disease was diagnosed according to the National Institute of Neurological and Communicative Disorders and Stroke & the Alzheimer's Disease and Related Disorders and Stroke criteria. 30 A diagnosis of mixed dementia [Alzheimer's disease (AD) plus vascular cognitive impairment (VCI)] was made if moderate to severe small vessel ischemic changes or cortical infarctions were present on brain MRI. VCI not demented was used to label those with extensive radiologic evidence of vascular impairment who, however, did not reach the threshold of dementia, that is, the deterioration in function sufficient to impair activities of daily living; these patients were not included in the ND group. The diagnosis of behavioral variant frontotemporal dementia (bvFTD) was made according to the Rascovsky criteria. 31 Mild cognitive impairment (MCI) was diagnosed according to the Petersen criteria. 32 We did not use biomarkers for amyloid or neurodegeneration (tau or fluorodeoxyglucose positron emission tomography) because these tests are currently not available at our institution for routine assessment and because they are currently not widely used for clinical decision-making in the National Health Service. Initial diagnoses in the ND group were, however, confirmed by clinical follow-up.
The diagnosis of FMD was based on the criteria proposed by Schmidtke et al 33 with the exception of the age cutoff of below 70 years. We considered this criterion overly restrictive because there have been previous reports of cases of "functional" memory problems in people aged over 70. 34, 35 All participants with a Patient Health Questionnaire-9 (PHQ9) score of > 15 (indicative of current depression) or symptoms of active moderate depression as judged by the clinician [and whose memory symptoms may have been due to depressive pseudodementia (DPD)], were excluded from further analysis. Participants were also screened for generalized anxiety disorder using the GAD7. However, in keeping with the criteria for the diagnosis of FMD proposed by Schmidtke and colleagues, they were not excluded from the study on the basis of General Anxiety Disorder 7 (GAD7) scores. This means that some patients with FMD included in this study will have had significant problems with anxiety symptoms other than anxiety about memory.
Like those with DPD, participants in whom memory problems were found to be due to VCI not related to dementia and those for whom the diagnosis remained uncertain were not further analyzed. Although VCI and DPD are important diagnostic categories, at this early stage of development we were keen to test the DSA methodology in only 2 homogenous diagnostic groups.
Part 1 of this study is based on analyses of the first 15 patients with ND and the first 15 patients with FMD whose conversational data were analyzable. Part 2 is based on the blinded analysis of the consecutive 5 next patients with ND and next 5 patients with FMD who agreed to participate in this study after the recruitment for part 1 of this study had been completed.
Data Preparation for CA
Video or audio recordings of the history-taking phase (from a patient's entry into the neurologist's office, to the start of cognitive testing) were transcribed in detail, using a transcription system capturing the timing of speech (eg, overlaps between speakers, pauses both within and between speaker turns), certain intonation and prosodic features of speech (falling/rising intonation, loudness, emphasis, sound stretching). 36 
Initial CA Approach
Interactions with patients with ND or FMD were subjected to examination using the perspective and methods of CA. CA is a microanalytic, qualitative method, but it is well suited to combination with statistical measures. It has been applied widely to medical interactions in exploratory research, 37, 38 in research aimed at improving the effectiveness of doctor-patient communication, 39, 40 and in assisting the diagnostic process in other conditions. 19, 38 It is particularly useful for the identification of detailed aspects of language use and communicative practices (eg, the ways in which patients with epilepsy "normalize" their seizure experiences, whereas patients with dissociative (nonepileptic) seizures "catastrophise" their seizure descriptions). 19 In their analysis, the CA experts involved in this project initially identified the methods individual patients (and accompanying others if present) used to describe memory problems to the doctor (see Elsey et al 20 and Jones et al 21 for details).
Part 1: Quantitative Examination of Qualitative Findings
On the basis of the findings of the initial qualitative analysis, 20, 21 we developed a DSA to provide a guide for the rating of potentially diagnostic features of communication and to transform qualitative observations into a numeric score ( Table 1 ). The DSA encourages analysts to comment and rate 9 separate items. An additional 5 items focus on triadic features that can only be observed if patients are accompanied during their memory clinic appointment. The DSA describes findings for each item more in keeping with ND (associated with a score of +1) or observations more in keeping with FMD (given a numeric score of −1). Items can also be judged as unratable and would be given a score of 0. Items could be considered unratable because the interactional behavior did not take place (for instance because the neurologist had not asked the specific question (eg, "who is more concerned about the memory problems?"), the performance provided mixed evidence, or was neither typical of that expected from patients with ND nor that of patients with FMD. Free-text fields are provided for each item allowing the analyst to describe the reasoning for their categorical judgement. Finally, the DSA asks the analyst to make a qualitative judgement taking account of the whole conversation profile. For each interactional feature scores range between 1 and −1 (1: in favor of ND; 0: undecided or unable to rate; −1: in favor of FMD). There are 9/14 (unaccompanied/accompanied) items to score, so the maximum score is 9/14 (unaccompanied/accompanied) and minimum score −9/−14 (unaccompanied/ accompanied). A high score corresponds to a stereotypical ND description; a low score to a stereotypical FMD description.
AP indicates accompanying person; DSA, diagnostic scoring aid; FMD, functional memory disorder; ND, neurological disorder.
The applicability of the DSA was initially tested by 1 CA expert using the DSA on the recordings and transcripts of the 30 cases previously analyzed in a purely qualitative way. The analyst categorized each item as more in keeping with ND, more in keeping with FMD or unrateable. This was translated into a numeric score for each item. Finally, item scores were added up to produce a total score for each patient. An area under the receiver operated characteristic curve (AUROC) statistic was carried out based on these numeric ratings to identify an optimal diagnostic cutoff score.
Part 2: Blinded Analysis Using a DSA
To test the discriminatory potential of the DSA, 2 CA experts independently rated an additional 10 doctor-patient encounters (5 consecutive cases in each group with ND and FMD). These cases had not been included in the initial qualitative or retrospective quantitative analyses. The conversation analysts were expected to predict the neurological diagnosis in these new cases on the basis of their qualitative analysis of the video recordings of the doctor-patient encounter and transcripts of these encounters, guided by the DSA. They were also asked to use the DSA to produce a numeric assessment score for each participant having provided a score for each DSA feature. The analysts were blinded to all additional medical or demographic information about these patients. Analysts were not aware of the numeric cut-off calculated by the AUROC statistic at the time of this analysis and were encouraged not simply to base their diagnostic prediction on patients' numeric score. In their overall qualitative judgement, this enabled them to place more diagnostic emphasis on particularly outstanding features. However, in addition to the number of cases correctly diagnosed by their qualitative judgement, we also report the number of cases correctly categorized on the basis of the DSA scores using the diagnostic cut-off calculated in part 1 of this study.
Statistical Analysis
Routinely collected clinical data on consenting and nonconsenting patients approached about this study were compared using t tests to ascertain the representativeness of the patient group included.
In part 1 of this study, the diagnostic potential of individual DSA items was examined using the Fisher exact tests. The significance of differences in median scores of the ND and FMD groups was determined using the MannWhitney U test. An AUROC statistic was used to identify an optimal numeric cut-off for the differentiation of ND and FMD. In part 2 of this study we report κ scores as a measure of the interrater reliability of focussed CA using the DSA. 
RESULTS
Part 1
Of 353 patients referred to the specialist memory clinic during the recruitment period and of 148 eligible to take part in this study, 36 declined to participate and 112 were enrolled (see Fig. 1 consolidated standards of reporting trials diagram). Three withdrew their consent subsequently, leaving 109 who completed the study. There were no significant differences in terms of age, sex, anxiety, depression, or Addenbrooke Cognitive Examination (ACE-R) scores between those who consented to take part and those who did not, suggesting that the participants were representative of the wider population served by this memory clinic. There was also no significant difference in terms of diagnostic mix between people who consented and people who did not consent (Supplementary Table 1 Clinical details of the patients included in the ND and FMD groups described here are provided in Table 2 . Two participants of the 20 with FMD had MRI brain scans reported as possible atrophy. They were both followed-up; 1 followed-up at 24 months was aware that they had been working in a very stressful job at time of the first consultation. At follow-up they had changed jobs and now had no memory complaints. The second person was followed-up at 18 months. The Montreal Cognitive Assessment (MoCA) was 26/30 at follow-up (prior ACE 85 and MoCA 22). They were functioning normally in a busy job. Two participants of 20 cases with ND had normal structural scans but one of these had abnormal single-photon emission computed tomography. The other was seen for follow-up at 12 months and ACE-R had decreased from 87 to 82, the clinical picture at this stage being consistent with AD.
In part 2 of the study, 3 of 5 FMD cases did not attend for neuropsychology testing, hence the missing MMSE scores in Table 2 . However, their ACE-R scores were 87, 96, and 97. Two had entirely normal neuroimaging and were discharged. One had an old caudate head infarct and on follow-up 1 year later was still working, managing a team. Repeat ACE-R was 96 (97 one year earlier). Also in part 2, 1 person with ND did not have detailed neuropsychological testing. Neuroimaging showed atrophy. On follow-up this patient showed significant cognitive impairment.
There were no significant differences in demographics, depression, anxiety, or ACE-R scores between ND participants in parts 1 and 2 or between FMD patients in the 2 parts of this study. In total, 20 of the 30 participants included in part 1, and 7 of 10 included in part 2 of this study were accompanied. Feature 11 (patient's head turn encouraging AP to answer a question directed at the patient) could not be rated in 2 of the accompanied encounters because participants had only consented to audio recording the interaction. Table 3 shows the analyst's DSA ratings of the interactions included in part 1 of this study. A more detailed description of the individual items can be found on the DSA form (additional web content). The median total score of the first 9 items of the DSA was +5 in the ND (range, +8 to −3) and −5 in the FMD group (range, 0 to −9; difference, P < 0.001).
The median total of the 5 additional items to be rated in accompanied encounters was 2 (range, +5 to −3) in the ND group and −1 (range, 1 to −5) in the FMD group (difference, P = 0.003). The fact that only one of the additional items to be rated in accompanied encounters For a full description of the items see Supplementary Appendix (Supplemental Digital Content 2, http://links.lww.com/MLR/B506). Some items were unratable because a particular question was not asked (eg. "who is most concerned?").
AP indicates accompanying person; DSA, diagnostic scoring aid; FMD, functional memory disorder; ND, neurological disorder; NS, not significant.
individually yielded a statistically significant between-group difference may (at least in part) be explained by the relatively small number of accompanied interactions available for analysis. In view of the fact that the additional item scores for accompanied interactions were only available for a subset of the encounters, only the first 9 items were used for the AUROC analysis and the estimation of a quantitative diagnostic threshold. The area under the receiver operator characteristic curve was 0.98 (Fig. 2) . At the optimal DSA score for the distinction of patients with ND from those with FMD of +1 (with DSA score above this threshold suggesting a diagnosis of ND) the DSA-derived total score identified patients with ND with a sensitivity of 86.7% and a specificity of 100%.
Results-Part 2
Quantitative Scoring Using the DSA (Blinded Results) Rater 1 was accurate in 10/10 cases, whereas rater 2 correctly predicted 9/10 diagnoses on the basis of DSAguided qualitative analysis (rater 1 was more experienced because of his involvement in part 1 of the project). The results were identical when the linguistic diagnostic prediction was based on the numeric DSA scores. The case misdiagnosed by rater 2 as FMD (when the ultimate medical diagnosis was ND) attracted the lowest score rater 1 gave to any of the patients assessed as having ND (+4) and the highest score rater 2 gave to any patients thought to have FMD (−1). This suggests that the patient misdiagnosed by rater 2 had an objectively ambiguous conversational profile, posing a particular discriminatory challenge. The differences in the 2 raters' diagnostic prediction was based on a single completely discordant judgment of DSA item 4 (ratings, 1 vs. −1) and on nonconcordant decisions (0 vs. 1 or 0 vs. −1) on DSA items 3, 7, 9, 13, and 14 (see Table 4 for further DSA scoring details).
Interrater Reliability of the DSA
In terms of the final diagnosis (either based on the 2 raters' qualitative judgements or the quantitative procedure using the diagnostic cut-off derived from the AUROC analysis), the raters agreed in 9/10 cases. The κ-value for the DSA procedure as a whole was therefore 0.8 (SE of κ = 0.19; 95% confidence interval, 0.44-1.0) suggesting "very good" interrater reliability. We also looked at the interrater reliability of the 123 individual +1, 0, or −1 ratings from part 2 of this study. Both ratings were fully concordant for 87 numeric scores (the scores from raters 1 and 2 were 1/1, 0/0, or −1/−1), nonconcordant for 30 and discordant for 6. This means that both raters agreed on 70.7% of the observations when agreement on 33.8% of the ratings would have been expected by chance. The κ-value for all 123 DSA-based ratings combined was 0.56 (SE of κ = 0.06; 95% confidence interval, 0.44-0.68), consistent with "moderate" interrater agreement. The 2 raters' scores for each item assessed in part 2 of the study and the κ-values of each individual item are shown in Table 3 .
DISCUSSION
Our previous qualitative work has demonstrated that it is possible to describe characteristic conversational profiles of patients describing cognitive problems due to ND or FMD based on their interactional and linguistic contributions to initial encounters in a memory clinic. 20, 21 However, in these descriptive studies, the conversation analysts who analyzed video recordings and audio recordings of memory clinic encounters between neurologists, patients, and (sometimes) APs were always aware of the patients' medical diagnoses during the analytic process. The present study is the first to demonstrate that these linguistic and interactional features can be used diagnostically to predict diagnoses of ND or FMD made on the basis of standard medical criteria. Moreover, we show that qualitative assessments can be structured and likely medical diagnoses formulated using a DSA with a numeric diagnostic cut-off. The fact that the linguistic raters involved in this study had no expertise in the medical assessment of patients presenting with memory problems, together with the relatively high level of agreement between the 2 raters, suggests that the raters did not base their diagnostic predictions on an ill-defined hunch but on robust and objectifiable interactional observations.
The correct classification of 9/10 by 1 rater and 10/10 by a second independent rater, and the very good interrater reliability of the DSA-guided procedure as a whole, suggest that the addition of the structured observation of interactional features can make a significant contribution to screening processes for ND. Importantly, this is one of the few studies of cognitive screening "tools" to include participants with FMD; most previous studies compared patients with memory impairment with healthy controls. The inclusion of a group of patients with memory complaints but no ND adds ecological validity to our findings. Compared with other studies set in clinical situations (such as a study exploring the screening potential of the 6CIT brief cognitive test in primary care) our approach seems to have greater reliability and validity. 9 Interactional and linguistic observations may increase the confidence of nonexpert clinicians to diagnose clear cases of FMD, enabling them to treat patients in primary care or to refer them on to services providing appropriate treatment for functional NDs. Importantly, the interactional and linguistic observations contributing to the diagnosis of FMD may allow clinicians to provide more effective reassurance by allowing them to demonstrate to patients that they are displaying good memory function in interaction. It should be possible for clinicians to pick up these features during routine clinic encounters. Previous studies in patients presenting with epileptic or dissociative (nonepileptic) seizures have demonstrated that doctors can learn to change their history-taking style to optimize patients' opportunities to demonstrate particular conversational behaviors and to make diagnostically useful interactional observations as they take a patient's history. 41 The DSA developed here could be modified and used in similar studies investigating whether clinicians can be trained to identify features, which have diagnostic value while talking to patients with memory problems.
This study has a number of limitations. First and foremost, we were only able to explore the potential of CA as a tool capable of predicting medical diagnoses in the setting of initial memory clinic encounters in a modest number of patients. Although the consecutive recruitment and the levels of statistical significance in between-group tests on a range of separate conversational features observed even in such a small patient group make it unlikely that our findings are spurious, it would be desirable to replicate our findings in a larger and more diverse group of patients. One particular limitation of our findings in this regard is that we excluded patients with depression and those with VCI from this first quantitative study of our method. These are important differential diagnoses, which will need to be picked up by screening procedures. Future larger studies will need to demonstrate that the inclusion of interactional and linguistic observations can contribute to screening or stratification procedures in which patients with these problems are allocated to the correct management pathways. We also recognized that the ND and FMD groups in this study were not age-matched as those with ND were significantly older. This is not surprising as the biggest risk factor for ND is increasing age. However, as younger patients with memory concerns are increasingly referred to specialist memory clinics it is important to include and compare all age groups in studies of this nature. Furthermore, the mean MMSE score of the ND group was lower than that of the FMD group (20.4 vs. 28.2), reflecting the relatively late stage in the development of cognitive disorders at which patients are Patients with medical diagnosis of FMD 1
Patients with a medical diagnosis of ND 1 currently first referred to specialist services. Only 4 of the patients in the ND groups had MCI. An optimal screening tool for the earliest stages of ND would need to be capable of picking up patients with MCI and near normal MMSE scores). This means that confirmatory studies capturing more patients at an earlier stage of ND will be required before the method described here can be embedded in screening procedures. The MMSE scores of the MCI patients included in this study were just above the standard cut-off score of 23 for this test, indicating that, although unimpaired in their activities of daily living, they already had extensive global cognitive impairment. We do not know how effective this tool will be at distinguishing MCI from FMD. Because a clinical diagnosis of MCI refers to a very heterogenous symptom profile, the distinction between MCI and FMD might be difficult and will require larger number of participants, along with prospective follow-up to investigate whether it can predict those who are at high risk of developing AD or other dementias. We have only studied native English speakers; findings may have been different in patients speaking other languages or those using English as a second language. Although several different doctors were involved in the clinic conversations studied here, it would also be important to test this procedure in different clinical settings (for instance in community-based clinics, during home visits, and in elderly-care settings). The fact that the ND group included patients with memory problems of different etiologies should not be considered a weakness of this study. Although it is likely the method used in this study could also be deployed to identify interactional differences between different ND (such as Alzheimer disease or bvFTD) the fact that we were able to distinguish clearly between patients with a range of ND and those with FMD demonstrates its potential for screening or stratifying patient management.
We did not have access to investigations confirming clinical diagnosis with tests documenting the presence of amyloid or tau (positron emission tomography or cerebrospinal studies), but this reflects current NICE guidelines (www.nice. org.uk/guidance/CG42) and our "medical" diagnoses were based on multidisciplinary assessment by experts including detailed neuropsychological testing and structural brain imaging as well as clinical follow-up.
Future studies will need to demonstrate how much diagnostic value the observation of interactional features can add to conventional brief cognitive screening tools. A combined approach with an automated low cost, high-speed system to analyze speech will require the use of technology rather than conversation analysts. One way in which the research described here can be taken forward involves the computerized analysis of speech which has shown some promise in distinguishing AD, MCI, and healthy controls. 16 Early indications are that computerized speech analysis and machine-learning algorithms can also be used to produce an automated system to pick up and evaluate the sort of interactional observations described here and can discriminate between ND and FMD. 22 More immediately, the findings described here can be used in the training of clinicians working with patients with memory problems.
